Published : Jan-2018
No. of Pages : 145
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Ablation Equipments Overview 8
3 Products under Development 9
3.1 Ablation Equipments - Pipeline Products by Stage of Development 9
3.2 Ablation Equipments - Pipeline Products by Territory 10
3.3 Ablation Equipments - Pipeline Products by Regulatory Path 11
3.4 Ablation Equipments - Pipeline Products by Estimated Approval Date 12
3.5 Ablation Equipments - Ongoing Clinical Trials 13
4 Ablation Equipments - Pipeline Products under Development by Companies 14
4.1 Ablation Equipments Companies - Pipeline Products by Stage of Development 14
4.2 Ablation Equipments - Pipeline Products by Stage of Development 15
5 Ablation Equipments Companies and Product Overview 16
5.1 AngioDynamics Inc Company Overview 16
5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 CPSI Biotech Company Overview 28
5.2.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 28
5.3 Creo Medical Ltd. Company Overview 30
5.3.1 Creo Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 Harmonic Medical Inc Company Overview 32
5.4.1 Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 32
5.5 HistoSonics Inc Company Overview 35
5.5.1 HistoSonics Inc Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 Hospital for Special Surgery Company Overview 38
5.6.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 38
5.7 Imricor Medical Systems Inc Company Overview 39
5.7.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.8 Innoblative Designs, Inc. Company Overview 42
5.8.1 Innoblative Designs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.9 Integra LifeSciences Holdings Corp Company Overview 43
5.9.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 43
5.10 Intratherm, Llc Company Overview 44
5.10.1 Intratherm, Llc Pipeline Products & Ongoing Clinical Trials Overview 44
5.11 Medtronic plc Company Overview 45
5.11.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 45
5.12 Memorial Sloan Kettering Cancer Center Company Overview 47
5.12.1 Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 47
5.13 Mirabilis Medical Inc Company Overview 48
5.13.1 Mirabilis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 48
5.14 Prosurg Inc Company Overview 51
5.14.1 Prosurg Inc Pipeline Products & Ongoing Clinical Trials Overview 51
5.15 Pulse Biosciences, Inc. Company Overview 52
5.15.1 Pulse Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.16 Southern Illinois University Carbondale Company Overview 57
5.16.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 57
5.17 Thermedical Inc Company Overview 58
5.17.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 58
5.18 TransEnterix, Inc. Company Overview 59
5.18.1 TransEnterix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.19 University of California San Francisco Company Overview 60
5.19.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 60
5.20 University of Texas at Austin Company Overview 61
5.20.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 61
5.21 University of Wisconsin-Stout Company Overview 62
5.21.1 University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview 62
6 Ablation Equipments- Recent Developments 63
6.1 Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors 63
6.2 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 63
6.3 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 66
6.4 Nov 07, 2017: Misonix Reports First Quarter Fiscal Year 2018 Financial Results 67
6.5 Nov 06, 2017: Ethicon Celebrates 130 Years of Transforming Surgery to Advance Patient Outcomes 68
6.6 Nov 03, 2017: Smith & Nephew Third Quarter 2017 Trading Report 68
6.7 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 69
6.8 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results 70
6.9 Oct 26, 2017: Stryker reports third quarter 2017 results 70
6.10 Oct 26, 2017: Integra LifeSciences Reports Third Quarter 2017 Financial Results 72
6.11 Oct 25, 2017: Baylis Medical's Kris Shah appointed to AdvaMed Accel Board of Directors 73
6.12 Oct 19, 2017: CLS signs supplier agreement with University of Texas Medical Branch and receives the first order 73
6.13 Oct 18, 2017: Relievant Medsystems Names Ray M. Baker, M.D. as Chief Medical Officer 74
6.14 Oct 09, 2017: Smith & Nephew: Notice of Chief Executive Officer's intention to retire by end of 2018 74
6.15 Oct 09, 2017: Notice of Chief Executive Officer's intention to retire by end of 2018 75
6.16 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 75
6.17 Oct 02, 2017: Smith & Nephew Announces Directorate Change 77
6.18 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results 77
6.19 Sep 26, 2017: Integra LifeSciences Provides Preliminary Assessment of Minor Damage to its Manufacturing Facility in Anasco, Puerto Rico 78
6.20 Sep 20, 2017: SonaCare Medical Reports that CMS Announces Increase to ASC Payment for HIFU Prostate Ablation 78
6.21 Sep 19, 2017: Relievant Medsystems Names Kevin Hykes Chief Executive Officer 79
6.22 Sep 19, 2017: HistoSonics Expands Leadership Team As It Accelerates Growth 79
6.23 Sep 18, 2017: Smith & Nephew Announces Change in Board of Directors 81
6.24 Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director 81
6.25 Sep 11, 2017: Pulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTx System 81
6.26 Aug 23, 2017: Misonix Appoints Joseph Dwyer as Chief Financial Officer 82
6.27 Aug 23, 2017: Baylis Medical strengthens global expansion plans with senior hire 82
6.28 Aug 22, 2017: Misonix Reports Fiscal Year 2017 Financial Results 83
6.29 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 84
6.30 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 87
6.31 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 87
6.32 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 87
6.33 Jul 27, 2017: Stryker reports second quarter 2017 results 91
6.34 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results 92
6.35 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 92
6.36 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 94
6.37 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer 96
6.38 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 96
6.39 Jun 29, 2017: FDA Confirms 510(K) Submission Pathway For Creo's Flexible Ablation System 97
6.40 Jun 19, 2017: CSA Medical Appoints Jean Bjerke, Vice President of Marketing 97
6.41 Jun 07, 2017: AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System 98
6.42 Jun 07, 2017: HistoSonics Announces Addition to Management Team 98
6.43 Jun 06, 2017: Pulse Biosciences Announces Treatment of First Patient in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation Technology for Seborrheic Keratosis Lesions 99
6.44 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 99
6.45 May 17, 2017: Syneron Medical Reports First Quarter 2017 Revenue of $66.9 Million 102
6.46 May 12, 2017: Smith & Nephew opens state-of-the-art Research & Development Centre 104
6.47 May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures 104
6.48 May 05, 2017: Smith & Nephew 2017 First Quarter Trading Report 105
6.49 May 04, 2017: AtriCure Reports First Quarter 2017 Financial Results 107
6.50 May 04, 2017: Olympus Extends Portfolio of EndoTherapy Solutions at DDW 108
6.51 May 02, 2017: Misonix Reports Third Quarter Fiscal Year 2017 Financial Results 109
6.52 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 109
6.53 Apr 25, 2017: Stryker reports first quarter 2017 results 111
6.54 Apr 20, 2017: Key Appointment to Board of Directors at Cianna Medical 112
6.55 Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results 113
6.56 Mar 23, 2017: Mirabilis Medical Announces European Approval for Non-Invasive Uterine Fibroid Treatment 114
6.57 Mar 23, 2017: Mirabilis receives FDA approval for US clinical study 115
6.58 Mar 14, 2017: Pulse Biosciences Submits 510(k) Application to FDA for PulseTx System 115
6.59 Mar 14, 2017: AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System 115
6.60 Mar 13, 2017: Misonix Announces Second Quarters of Fiscal 2017 116
6.61 Mar 13, 2017: HistoSonics Appoints Mike Blue as CEO and Board Member 117
6.62 Mar 13, 2017: Misonix Files Forms 10-Q for First and Second Quarters of Fiscal 2017 117
6.63 Mar 06, 2017: AtriCure Announces hiring of Senior Vice President of Clinical, Regulatory, and Scientific Affairs 119
6.64 Mar 06, 2017: TransEnterix Reports Operating Results for the Fourth Quarter and Full Year 2016 119
6.65 Feb 28, 2017: AtriCure Reports Fourth Quarter and Full Year 2016 Financial Results 120
6.66 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 121
6.67 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 123
6.68 Feb 15, 2017: Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million 126
6.69 Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results 127
6.70 Feb 09, 2017: Smith & Nephew: Directorate Change 132
6.71 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 132
6.72 Jan 31, 2017: Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer 133
6.73 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 134
6.74 Jan 17, 2017: Aurora Cancer Care is first in Wisconsin to perform new Nanoknife therapy technique to treat pancreatic and liver cancers 135
6.75 Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew 136
6.76 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 136
6.77 Jan 09, 2017: AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2016 138
6.78 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 139
6.79 Dec 19, 2016: Stavros G. Vizirgianakis Appointed President and CEO of Misonix 140
7 Appendix 142
7.1 Methodology 142
7.2 About GlobalData 145
7.3 Contact Us 145
7.4 Disclaimer 145
1.1 List of Tables
Table 1: Ablation Equipments - Pipeline Products by Stage of Development 9
Table 2: Ablation Equipments - Pipeline Products by Territory 10
Table 3: Ablation Equipments - Pipeline Products by Regulatory Path 11
Table 4: Ablation Equipments - Pipeline Products by Estimated Approval Date 12
Table 5: Ablation Equipments - Ongoing Clinical Trials 13
Table 6: Ablation Equipments Companies - Pipeline Products by Stage of Development 14
Table 7: Ablation Equipments - Pipeline Products by Stage of Development 15
Table 8: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 9: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Status 16
Table 10: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Description 17
Table 11: NanoKnife System - Pancreatic Cancer - Product Status 17
Table 12: NanoKnife System - Pancreatic Cancer - Product Description 17
Table 13: NanoKnife System - Prostate Cancer - Product Status 18
Table 14: NanoKnife System - Prostate Cancer - Product Description 18
Table 15: Next Generation NanoKnife System - Product Status 18
Table 16: Next Generation NanoKnife System - Product Description 19
Table 17: AngioDynamics Inc - Ongoing Clinical Trials Overview 20
Table 18: NanoKnife System - Prostate Cancer - Irreversible Electroporation(IRE) for Unresectable Prostatic Neoplasms: Phase I and Phase II Clinical Trial 21
Table 19: NanoKnife System - Prostate Cancer - Multi-center Randomized Clinical Two Arm Intervention Study Evaluating Irreversible Electroporation for the Ablation of Localized Prostate Cancer 21
Table 20: NanoKnife System - Pancreatic Cancer - A Clinical Research about Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer 22
Table 21: NanoKnife System - Pancreatic Cancer - A Pilot Study of Irreversible Electroporation for the Treatment of Upfront Resectable Pancreatic Cancer in the Head of the Pancreas 22
Table 22: NanoKnife System - Pancreatic Cancer - Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study 22
Table 23: NanoKnife System - Pancreatic Cancer - IRE: Anti-tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer 23
Table 24: NanoKnife System - Pancreatic Cancer - Pilot-study: Non-thermal Ablation Using Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma - A Phase I Clinical Trial - PANFIRE 23
Table 25: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation (IRE) for the Treatment of Unresectable Hepatic Carcinoma Close to the Gallbladder 24
Table 26: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers 24
Table 27: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Colorectal Metastatic Liver Disease: Efficacy of Irreversible Electroporation (IRE) - A Phase II Clinical Trial (COLDFIRE-2 Study) 24
Table 28: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer 25
Table 29: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Comparison Percutaneous Cryosurgery and Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome 25
Table 30: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Hepatic Carcinoma in Poor Liver Function: Safety and Efficacy of Irreversible Electroporation (IRE) 25
Table 31: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Irreversible Electroporation (IRE) for Unresectable Portal Venous Tumor Emboli: Phase I and Phase II Clinical Trial 26
Table 32: Next Generation NanoKnife System - The Safety and Feasibility of Irreversible Electroporation for the Ablation of Small Renal Masses 27
Table 33: CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 28
Table 34: Pressurized Sub-Cooled Nitrogen System - Product Status 28
Table 35: Pressurized Sub-Cooled Nitrogen System - Product Description 28
Table 36: Super-Critical Nitrogen (SCN) Cryoablation Platform - Product Status 29
Table 37: Super-Critical Nitrogen (SCN) Cryoablation Platform - Product Description 29
Table 38: Creo Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 39: Flexible Ablation System - Product Status 30
Table 40: Flexible Ablation System - Product Description 30
Table 41: Lung Ablation Device - Product Status 31
Table 42: Lung Ablation Device - Product Description 31
Table 43: Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 44: Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - Product Status 32
Table 45: Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - Product Description 32
Table 46: Harmonic Medical Inc - Ongoing Clinical Trials Overview 33
Table 47: Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - MRI-guided High Intensity Focused Ultrasound Ablation of Leiomyomas. Single Arm, Feasibility Study Using the Symphony - MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas. 34
Table 48: HistoSonics Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 49: Vortx RX - Product Status 35
Table 50: Vortx RX - Product Description 35
Table 51: HistoSonics Inc - Ongoing Clinical Trials Overview 36
Table 52: Vortx RX - Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US) 37
Table 53: Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 38
Table 54: Radiofrequency Ablation Device - Product Status 38
Table 55: Radiofrequency Ablation Device - Product Description 38
Table 56: Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 57: Vision MR Ablation Catheter - Product Status 39
Table 58: Vision MR Ablation Catheter - Product Description 39
Table 59: Imricor Medical Systems Inc - Ongoing Clinical Trials Overview 40
Table 60: Vision MR Ablation Catheter - Cardiovascular Magnetic Resonance-guided Radiofrequency-Ablation for Atrial Flutter 41
Table 61: Vision MR Ablation Catheter - Evaluation of MR-enabled Systems in the Treatment of Atrial Flutter: A Prospective Pilot Study 41
Table 62: Innoblative Designs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
Table 63: RFA Applicator - Product Status 42
Table 64: RFA Applicator - Product Description 42
Table 65: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 43
Table 66: CUSA Ultrasonic Tissue Ablation System - Liver - Product Status 43
Table 67: CUSA Ultrasonic Tissue Ablation System - Liver - Product Description 43
Table 68: Intratherm, Llc Pipeline Products & Ongoing Clinical Trials Overview 44
Table 69: CITT Device - Product Status 44
Table 70: CITT Device - Product Description 44
Table 71: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 72: Barrx 360 Express RFA Balloon Catheter - Product Status 45
Table 73: Barrx 360 Express RFA Balloon Catheter - Product Description 45
Table 74: Nerve Cryoablation System - Product Status 46
Table 75: Nerve Cryoablation System - Product Description 46
Table 76: Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 47
Table 77: Image-Guided Ablation Device - Product Status 47
Table 78: Image-Guided Ablation Device - Product Description 47
Table 79: Mirabilis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 80: Mirabilis System - Product Status 48
Table 81: Mirabilis System - Product Description 48
Table 82: Mirabilis Medical Inc - Ongoing Clinical Trials Overview 49
Table 83: Mirabilis System - Directed Ablation of Uterine Fibroids Using a Noninvasive Approach: DIANA 50
Table 84: Prosurg Inc Pipeline Products & Ongoing Clinical Trials Overview 51
Table 85: ImaGel - Product Status 51
Table 86: ImaGel - Product Description 51
Table 87: Pulse Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
Table 88: PulseTx System - Seborrheic Keratosis - Product Status 52
Table 89: PulseTx System - Seborrheic Keratosis - Product Description 52
Table 90: PulseTx System - Soft Tissue Ablation - Product Status 53
Table 91: PulseTx System - Soft Tissue Ablation - Product Description 53
Table 92: Pulse Biosciences, Inc. - Ongoing Clinical Trials Overview 54
Table 93: PulseTx System - Soft Tissue Ablation - First-of-its-kind PulseTx System in Pilot Study in Dermatology 55
Table 94: PulseTx System - Seborrheic Keratosis - Clinical Evaluation of Safety and Efficacy of Nano-pulse Stimulation Technology for Seborrheic Keratosis Lesions 56
Table 95: Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 57
Table 96: Thermoablation Probe - Product Status 57
Table 97: Thermoablation Probe - Product Description 57
Table 98: Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 99: SERF Ablation System - Fibroids - Product Status 58
Table 100: SERF Ablation System - Fibroids - Product Description 58
Table 101: TransEnterix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
Table 102: Barrett's Excision Device - Product Status 59
Table 103: Barrett's Excision Device - Product Description 59
Table 104: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 60
Table 105: Robotic Needle Ablation Tool And Securement Device - Product Status 60
Table 106: Robotic Needle Ablation Tool And Securement Device - Product Description 60
Table 107: University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 61
Table 108: Plasmonic Laser Ablation Device - Product Status 61
Table 109: Plasmonic Laser Ablation Device - Product Description 61
Table 110: University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview 62
Table 111: Microwave Ablation Probe - Product Status 62
Table 112: Microwave Ablation Probe - Product Description 62
Table 113: Glossary 144
1.2 List of Figures
Figure 1: Ablation Equipments - Pipeline Products by Stage of Development 9
Figure 2: Ablation Equipments - Pipeline Products by Territory 10
Figure 3: Ablation Equipments - Pipeline Products by Regulatory Path 11
Figure 4: Ablation Equipments - Pipeline Products by Estimated Approval Date 12
Figure 5: Ablation Equipments - Ongoing Clinical Trials 13
